Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

NCT05002556

Conditions
Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
Locations
  • Hopital Prive de Provence Aix-en-Provence, France
  • CHU Angers Angers, France
  • Hopital Privé Arras les Bonnettes Arras, France
  • Centre hospitalier Privé Montgradé Aubergenville, France
View all 44 locations
View Trial Details
Recruiting

International (Pediatric) Peritoneal Biobank

NCT01893710

Conditions
Cardiovascular Diseases, Chronic Disease, Disease Attributes, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
  • The Children´s Hospital of Philadelphia Narberth, Pennsylvania, United States
  • Department of Pediatrics, Medical University Vienna Vienna, Austria
View all 26 locations
View Trial Details
Recruiting

Evaluation of the Safety and Performance of the Hydrustent® Biodegradable Hydrogel Ureteral Stent

NCT06719089

Conditions
Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Unidade Local de Saúde da Região de Aveiro (ULSRA), E.P.E. Aveiro, Aveiro District, Portugal
  • Unidade Local de Unidade Local de Saúde do Alto Ave (ULSAAVE), E.P.E Guimarães, Braga District, Portugal
  • Hospital CUF Tejo Lisbon, Portugal
  • Unidade Local de Saúde do Alto Minho (ULSAM) Viana do Castelo, Portugal
View Trial Details
Recruiting

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT05935215

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Novartis Investigative Site Nanjing, Jiangsu, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Shanghai, China
View all 31 locations
View Trial Details
Recruiting

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

NCT05383274

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +5 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Orlando Health Orlando, Florida, United States
  • Florida Urology Tampa, Florida, United States
  • Regional Urology Shreveport, Louisiana, United States
View Trial Details
Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

NCT06413680

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +28 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Yale School of Medicine North Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions